CT News and Research

RSS

Mayo Clinic receives FDA approval for Choline C 11 Injection to help detect prostate cancer

The U.S. Food and Drug Administration today approved the production and use of Choline C 11 Injection, a Positron Emission Tomography (PET) imaging agent used to help detect recurrent prostate cancer.

13 Sep 2012

Roundup: Mich. Gov. proposes making BCBS a tax-paying insurer; Merger creates one of largest hospitals in Conn.; W. Va. chiropractor board scrutinized

Blue Cross Blue Shield of Michigan would no longer be exempt from about $100 million a year in state and local taxes but would be subject to more streamlined and speedier rate reviews and approvals under legislation proposed today by Gov. Rick Snyder. The nonprofit health insurer would also pay $1.5 billion over 18 years into a separate nonprofit aimed at tackling issues such as obesity and infant mortality to improve the health of all Michigan residents, Snyder said at a news conference.

13 Sep 2012

UB researchers receive NFL grant for sports-related medical research on concussion

After sustaining a concussion, when can an athlete safely return to play? That's the primary question for professional and amateur athletes alike. Now, University at Buffalo sports medicine researchers have been awarded $100,000 from NFL Charities to develop the most objective, scientific method of determining when an athlete who has had a concussion can safely return to play.

12 Sep 2012

CT shows promise in predicting COPD exacerbation risk

Measurement of the pulmonary artery-to-aorta ratio can predict the risk for exacerbations in patients with chronic obstructive pulmonary disease, particularly those that require hospitalization, say the authors of a US study.

11 Sep 2012

GE Healthcare announces data from [18F]flutemetamol phase III studies on Alzheimer's

GE Healthcare today announced pooled results from phase III brain autopsy and biopsy studies on the investigational PET amyloid imaging agent, [18F]flutemetamol, which showed a strong concordance between [18F]flutemetamol images and Alzheimer's disease-associated beta amyloid brain pathology.

11 Sep 2012

First Edition: September 11, 2012

Today's headlines explore how, based on his recent comments, Mitt Romney's health law replacement goals could become tricky.

11 Sep 2012

Blood flow simulation tools can test and optimize Berlin Heart design

Structural and mechanical engineers at the University of California, San Diego, are working together to create blood flow simulations that could lead to improvements in the design of a cardiac pump for children born with heart defects. They hope that the design changes will improve young patients' outcomes.

11 Sep 2012

Kaleida Health's Gates Vascular Institute installs Vantage Titan 3T MR system from Toshiba

Providing patient-friendly 3T MR imaging with outstanding image quality, Kaleida Health's Gates Vascular Institute (GVI) in Buffalo, N.Y., installed the Vantage Titan 3T MR system from Toshiba America Medical Systems, Inc., the 1,400th Vantage MR installation worldwide.

11 Sep 2012

Concussion: an interview with Dr Rob Reid

Concussion happens when something produces a concussive force to the head, such as a blow to the head. The definition from the 2008 consensus, which was in Zurich, is, “concussion is defined as a complex pathophysiological process affecting the brain, induced by traumatic biomechanical forces.”

10 Sep 2012

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

AMAG Pharmaceuticals, Inc. today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization in Switzerland for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease.

6 Sep 2012

F-18-FDG PET/CT may easily predict disease-free survival for invasive ductal breast cancer patients

Disease-free survival for invasive ductal breast cancer (IDC) patients may be easier to predict with the help of F-18-fludeoxyglucose positron emission tomography (PET)/computed tomography (CT) scans, according to research published in the September issue of The Journal of Nuclear Medicine. New data show that high maximum standard uptake value (SUVmax) of F-18-FDG in the lymph nodes prior to treatment could be an independent indicator of disease recurrence.

6 Sep 2012

European regulators approve Surefire Infusion System for chemo- and radioembolization procedures

European regulators have approved Surefire Medical's Surefire Infusion System, a next generation device for chemo- and radioembolization procedures. The Colorado-based medical device company today announced that it is launching this product in the European market immediately.

5 Sep 2012

Smoker's pack-years, age and area of emphysema are strong predictors of mortality in COPD

Identifying an individual's the smoking history could help doctors to predict survival time in people with COPD.

5 Sep 2012

Regional PACS networks may be useful in reducing cost and radiation exposure associated with trauma

According to a study in the Sept. issue of the Journal of the American College of Radiology, using a combination of the Internet and compact discs (CD) to transfer images during inter-hospital transfer is associated with much lower repeat imaging rates, suggesting that regional PACS networks may be useful for reducing cost and radiation exposure associated with trauma.

4 Sep 2012

$Noninvasive fractional flow reserve still out of reach$

Noninvasive fractional flow reserve still out of reach

A novel, noninvasive approach to determining fractional flow reserve failed to show sufficient diagnostic accuracy to meet the primary endpoint of the DeFACTO trial, but was more accurate for diagnosing coronary artery ischemia than computed tomography, reported the trial’s lead investigator.

3 Sep 2012

VIDA releases Apollo 1.2 SaaS for endobronchial emphysema treatment

VIDA Diagnostics, a leading developer of quantitative imaging analysis software for the diagnosis and treatment planning of major pulmonary disease, announced today the release and commercial availability of Apollo 1.2, here at the European Respiratory Society (ERS) meeting in Vienna, Austria.

3 Sep 2012

CT scan appears to predict risk of chronic obstructive pulmonary disease exacerbations

The respective size of two major arteries, visible on a simple computed tomography, or CT, scan, is a strong predictor of the risk of exacerbation of chronic obstructive pulmonary disease, according to new research from the University of Alabama at Birmingham published online Sept. 3, 2012, in the New England Journal of Medicine.

3 Sep 2012

Boehringer Ingelheim announces data from olodaterol plus tiotropium Phase II COPD study

Boehringer Ingelheim presented today for the first time data from a Phase II dose ranging study investigationg the combination of olodaterol, an investigational long-acting beta2-agonist (LABA), and tiotropium, a long-acting muscarinic antagonist (LAMA), in COPD patients, compared to the investigational agent olodaterol alone.

3 Sep 2012

First data from Boehringer Ingelheim’s Respimat Phase III asthma program

Boehringer Ingelheim presented today the first data from the Phase III UniTinA-asthma program. In two studies, presented at the 2012 European Respiratory Society (ERS) Congress in Vienna, Austria, tiotropium delivered once daily via the Respimat inhaler significantly improved lung function and reduced asthma exacerbations in patients who remained symptomatic on current treatment with at least high dose inhaled corticosteroids (ICS) and long-acting beta agonists (LABA).

3 Sep 2012

DNA synthesis in the 3’ and 5’ direction possible using new template-directed method

When a cell divides, it passes on genetic information by producing copies of its DNA. Chemists have also learned to copy DNA. In the journal Angewandte Chemie, a German team has now introduced a new copying technique that uses a single strand of DNA as the “master copy”, like a cell, but does not require enzymes.

30 Aug 2012

CT News and Research

Mayo Clinic receives FDA approval for Choline C 11 Injection to help detect prostate cancer

Roundup: Mich. Gov. proposes making BCBS a tax-paying insurer; Merger creates one of largest hospitals in Conn.; W. Va. chiropractor board scrutinized

UB researchers receive NFL grant for sports-related medical research on concussion

CT shows promise in predicting COPD exacerbation risk

GE Healthcare announces data from [18F]flutemetamol phase III studies on Alzheimer's

First Edition: September 11, 2012

Blood flow simulation tools can test and optimize Berlin Heart design

Kaleida Health's Gates Vascular Institute installs Vantage Titan 3T MR system from Toshiba

Concussion: an interview with Dr Rob Reid

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

F-18-FDG PET/CT may easily predict disease-free survival for invasive ductal breast cancer patients

European regulators approve Surefire Infusion System for chemo- and radioembolization procedures

Smoker's pack-years, age and area of emphysema are strong predictors of mortality in COPD

Regional PACS networks may be useful in reducing cost and radiation exposure associated with trauma

Noninvasive fractional flow reserve still out of reach

VIDA releases Apollo 1.2 SaaS for endobronchial emphysema treatment

CT scan appears to predict risk of chronic obstructive pulmonary disease exacerbations

Boehringer Ingelheim announces data from olodaterol plus tiotropium Phase II COPD study

First data from Boehringer Ingelheim’s Respimat Phase III asthma program

DNA synthesis in the 3’ and 5’ direction possible using new template-directed method

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News